Prostate cancer screening has long relied on blood tests, MRIs, and biopsies, each carrying its own set of drawbacks, such as causing discomfort and leading to the overdiagnosis of low-grade cancers that might not pose significant health risks. These traditional approaches, while effective in
The laboratories of today face numerous challenges that call for heightened efficiency, accuracy, and streamlined workflows, creating a pressing need for reliable automation solutions. Responding to these demands, Tecan has introduced Veya™, a cutting-edge liquid handling platform designed to r
The current landscape of behavioral health startups is marked by a competitive funding environment. Companies in this sector face numerous challenges as they strive to secure capital, navigate investment trends, and differentiate themselves in a crowded market. This article explores these dynamics,
The potential breakthrough in treating liver cirrhosis caused by metabolic dysfunction-associated steatohepatitis (MASH) has come from a recent study by Akero Therapeutics. Efruxifermin, an experimental drug, has shown significant promise in reversing liver damage in patients suffering from this
The University of Kentucky (UK) researchers are currently engaged in a groundbreaking clinical trial aimed at exploring the potential benefits of medical cannabis in managing symptoms of late-stage dementia. This study, officially named the LiBBY Study, is backed by both the National Institutes of
Digital health technologies, including artificial intelligence, analytics, dashboards, web portals, mobile applications, virtual care, and wearables, hold transformative potential for diagnosis, treatment, and care management. However, their successful implementation and uptake in real-world
BeiGene Ltd., one of China's foremost developers of next-generation cancer drugs, is on the cusp of turning a profit after years of significant investments in research and development. The company has made remarkable strides towards achieving an annual operating profit, bolstered by the
The field of regenerative medicine is poised to revolutionize healthcare by 2030. With rapid advancements in stem cell therapy, gene therapy, and tissue engineering, this innovative sector offers groundbreaking treatments for a wide array of health conditions. From chronic diseases to injuries and
Lupus, a chronic autoimmune disease, has long been a challenging condition to manage, often requiring treatments that come with severe side effects and necessitate lifelong administration. However, recent advancements in Chimeric Antigen Receptor (CAR) T cell therapies are providing new hope for
The intersection of artificial intelligence (AI) and bioprocess development has paved the way for groundbreaking advancements in the life sciences sector. One particularly exciting development in this domain is the collaboration between Eppendorf SE, a leading life sciences company, and DataHow AG,
